| X24-05-ZQ670 |
EGFR-HER2 inhibitor Lavendustin A, Purity ≥98%
|
|
| X24-05-ZQ671 |
EGFR-HER2 inhibitor AG-99, Purity ≥98%
|
|
| X24-05-ZQ672 |
EGFR-HER2 inhibitor AG-494, Purity ≥98%
|
|
| X24-05-ZQ673 |
EGFR-HER2 inhibitor Afatinib, Purity ≥98%
|
|
| X24-05-ZQ674 |
EGFR-HER2 inhibitor RG14620, Purity ≥98%
|
|
| X24-05-ZQ675 |
EGFR-HER2 inhibitor AG 555, Purity ≥98%
|
|
| X24-05-ZQ676 |
EGFR-HER2 inhibitor EGFR-IN-7, Purity ≥98%
|
|
| X24-05-ZQ677 |
EGFR-HER2 inhibitor Mutated EGFR-IN-2, Purity ≥98%
|
|
| X24-05-ZQ678 |
EGFR-HER2 inhibitor DBPR112, Purity ≥98%
|
|
| X24-05-ZQ679 |
EGFR-HER2 inhibitor Tarloxotinib bromide, Purity ≥98%
|
|
| X24-05-ZQ680 |
EGFR-HER2 inhibitor Mutant EGFR inhibitor, Purity ≥98%
|
|
| X24-05-ZQ681 |
EGFR-HER2 inhibitor HS-10296 hydrochloride, Purity ≥98%
|
|
| X24-05-ZQ682 |
EGFR-HER2 inhibitor AST2818 mesylate, Purity ≥98%
|
|
| X24-05-ZQ683 |
EGFR-HER2 inhibitor Nazartinib mesylate, Purity ≥98%
|
|
| X24-05-ZQ684 |
EGFR-HER2 inhibitor Nazartinib S-enantiomer, Purity ≥98%
|
|
| X24-05-ZQ685 |
EGFR-HER2 inhibitor Pyrotinib dimaleate, Purity ≥98%
|
|
| X24-05-ZQ686 |
EGFR-HER2 inhibitor Epertinib hydrochloride, Purity ≥98%
|
|
| X24-08-YM001 |
EGFR-HER2 inhibitor, Lifirafenib, Purity ≥98%
|
|
